Contract Manufacturing, General

Jul 24, 2018
By BioPharm International Editors
The API and drug product provider will invest £375,000 (US$493,000) in additional nuclear magnetic resonance (NMR) instrumentation at its headquarters in Craigavon, UK.
Jul 01, 2018
BioPharm International
This article highlights 15 years of changes in biopharmaceutical manufacturing.
Jun 01, 2018
By BioPharm International Editors
Madison Dearborn Partners will acquire a majority ownership position in CDMO Alcami.
Jun 01, 2018
By BioPharm International Editors
TxCell announces manufacturing agreement with Lonza for its HLA-A2 CAR-Treg cellular product.
May 03, 2018
By BioPharm International Editors
The company has begun expansion efforts for its process-development capabilities and laboratory infrastructure.
May 01, 2018
BioPharm International
More published data and initial regulatory approvals are needed to drive adoption of continuous bio-manufacturing.
Apr 01, 2018
BioPharm International
Developments and investments in single-use systems advance upstream biomanufacturing.
Apr 01, 2018
BioPharm International
Early adopters are benefiting from lower costs and increased productivity.
Mar 15, 2018
BioPharm International
Research suggests that working with a single contract partner can reduce development time and improve economics.
Mar 15, 2018
BioPharm International
A different perspective on controlling fixed costs of biomanufacturing, based on know-how from other industries, provides a competitive edge, says the CEO of Samsung BioLogics.
native1_300x100
lorem ipsum